David Horst
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
- Oncology 68
- Cancer Cells and Metastasis 24
- Colorectal Cancer Treatments and Studies 12
- Cancer Immunotherapy and Biomarkers 9
-
- Wnt/β-catenin signaling in development and cancer 15
- Cancer-related gene regulation 9
- Co-authors
- Thomas Kirchner (44 shared papers)Andreas Jung (23 shared papers)Heiko Hermeking (18 shared papers)Lydia Kriegl (11 shared papers)Matjaž Rokavec (6 shared papers)Jutta Engel (13 shared papers)Markus Kaller (6 shared papers)Florian R. Greten (5 shared papers)
- Journals
- Clinical Cancer Research (7 papers)Journal of Clinical Oncology (6 papers)Scientific Reports (5 papers)PLoS ONE (5 papers)Cancer Research (5 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
David Horst
156 papers receiving 6.2k citations
David Horst's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 1.6k
- Oncology 2.1k
- Molecular Biology 2.7k
- Immunology 597
- Pathology and Forensic Medicine 394
Countries citing papers authored by David Horst
This map shows the geographic impact of David Horst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Horst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Horst more than expected).
Fields of papers citing papers by David Horst
This network shows the impact of papers produced by David Horst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Horst. The network helps show where David Horst may publish in the future.
Co-authors
The 25 scholars most cited alongside David Horst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis Hit paper breakdown → | 2014 | 631 |
| 2 | Targeting non-coding RNAs to overcome cancer therapy resistance Hit paper breakdown → | 2022 | 288 |
| 3 | 2017 | 281 | |
| 4 | 2008 | 269 | |
| 5 | Causes of death and comorbidities in hospitalized patients with COVID-19 Hit paper breakdown → | 2021 | 258 |
| 6 | 2012 | 241 | |
| 7 | 2012 | 217 | |
| 8 | 2009 | 178 | |
| 9 | 2010 | 153 | |
| 10 | 2009 | 147 | |
| 11 | 2021 | 143 | |
| 12 | 2017 | 132 | |
| 13 | 2013 | 130 | |
| 14 | 2012 | 126 | |
| 15 | 2011 | 111 | |
| 16 | 2012 | 95 | |
| 17 | 2011 | 92 | |
| 18 | 2011 | 88 | |
| 19 | 2005 | 81 | |
| 20 | 2016 | 80 |
About David Horst
David Horst is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 176 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (24 papers), Genetic factors in colorectal cancer (18 papers), Cancer Genomics and Diagnostics (16 papers), Wnt/β-catenin signaling in development and cancer (15 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related gene regulation (9 papers) and Bladder and Urothelial Cancer Treatments (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.1k citations), Molecular Biology (2.7k citations), Immunology (597 citations) and Pathology and Forensic Medicine (394 citations). David Horst has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Thomas Kirchner, Andreas Jung, Heiko Hermeking, Lydia Kriegl, Matjaž Rokavec, Jutta Engel, Markus Kaller, Florian R. Greten, René Jackstadt and Jens Neumann. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Scientific Reports, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.